The incidence of resistance to antibiotics from infections is rising with new therapies and strategies required. One recent approach has been to combine antimicrobial silver and antibiotics such as vancomycin to combat infections. However, since antibiotics and silver do not form adducts (i.e., interact with one another), disease-causing organisms may be exposed to marked variations in the amounts of silver or the antibiotic. The antimicrobial peptide, bHKP, forms an adduct with silver ions. As a result, this ensures that the disease-causing organism will be exposed to similar levels of both active agents (peptide and silver), thereby markedly augmenting antifungal activity.

Fig. 1. Proposed mechanism of the Branched Peptide (bHKP)-Silver Adduct: After the bHKP peptide-silver adduct is taken up by the fungi, the peptide is partially digested by enzymes with release of the silver ion. Fragments of bHKP peptide and silver act on targets in the fungi, perhaps the mitochondria (M).

Prior to the formation of the adduct between the silver and antimicrobial peptide, we modified the peptide to improve its activity against fungi. Antimicrobial peptides are ubiquitous in nature and have garnered increased attention in research labs and the biotech industry because of increased resistance to existing antimicrobials agents. We have previously determined that a branched peptide (bHKP) comprised of a specific amino acid sequences of histidines and lysines has marked antifungal activity. Because reduced activity of the antimicrobial bHKP peptide may be due to its digestion, one approach to mitigate enzymatic breakdown has been to incorporate D-amino acids (the mirror image of the more common L-amino acids in nature) within the peptide. The greater the D-amino acid content of a peptide, the slower the enzymatic breakdown of the bHKP peptide by disease-causing fungi. As a result, to maximize antifungal activity, bHKP was modified by varying its L- and D- amino acid content and subsequently bHKP and its analogues were compared for their ability to inhibit growth of fungi.  Surprisingly, replacement of all L-amino acids in the branches with D-amino acids reduced the antifungal activity of bHKP, but replacement of either L-histidines OR L-lysines with their D-counterparts markedly improved the antifungal activity of bHKP. The implication from this experiment is that the Goldilocks principle applies: that is, too little or too much degradation of bHKP decreases antifungal activity, yet partial enzymatic breakdown of bHKP is necessary for optimal activity.

Because histidines are known to interact with silver ions, bHKP with its 48 histidines (and 20 lysines) can readily entrap one or two silver ions within its four-branches.  Notably, the adduct between bHKP and silver showed a marked increase in its antifungal activity, particularly for tissue-invasive Aspergillus species. Against the Aspergillus species, the silver adduct of bHKP had increased antifungal activity compared to the bHKP peptide or silver alone by 30- and 26-fold, respectively. Similar to the peptide alone, bHKP containing all D-amino acids showed the least antifungal activity with silver.

In addition to demonstrating that partial breakdown of the peptide adduct is necessary for optimal activity, a partially degraded bHKP may more readily release the tightly bound silver ion to reach its target within the fungus (Fig. 1). Moreover, since silver and bHKP given sequentially had significantly less antifungal activity, the formation of an adduct and its intracellular uptake by fungi were likely necessary for maximal activity. The combination of two antifungal drugs, silver and bHKP, into one drug is a novel strategy to increase the therapeutic efficacy and reduce development of resistance by disease-causing fungi. Future studies will focus on coupling a targeting compound to the peptide-silver adduct to increase efficacy.

Qixin Leng and A. James Mixson
Department of Pathology, University of Maryland School of Medicine,
Baltimore, USA

Publication

Silver adducts of four-branched histidine rich peptides exhibit synergistic antifungal activity.
Leng Q, Woodle MC, Liu Y, Mixson AJ
Biochem Biophys Res Commun. 2016 Sep 2

Read offline:     

Related Articles:

	Campylobacter antimicrobial resistance in dogs and humans Campylobacteriosis has been the most frequently reported zoonotic disease in humans in Europe since 2005, and the annual number of notified   campylobacteriosis   cases   has   increased in   many   European countries in…
	BioID screen for bacterial virulence proteins: new… The discovery of penicillin in the 1920s revolutionized our ability to treat bacterial infection. However despite the introduction of antibiotics, infectious bacterial pathogens remain an immense challenge for the healthcare…
	Actinobacteria from Algerian ecosystems as a rich… Secondary metabolites are molecules not essential for the growth and development of microorganism, mainly having a defence role. They have shown a great potential for the discovery of drugs and…
	Rabbits with mammary carcinomas as a model for… Within a breeding colony of rabbits, the American pathologist Harry Greene (1904-1969) observed that mammary carcinomas were restricted to certain families. This is suggestive of a familiar predisposition as it…
	Linking copper, tyrosines and protein aggregation in… The prevalence of Alzheimer’s disease (AD), the most common cause of dementia nowadays, is expected to increase within the coming years, representing a serious threat for society and the healthcare…
	Making Christmas trees under duress, or how cells… Some of the most enduring images for a molecular biologist are electron microscopy micrographs of the so-called “Christmas trees”, famously first observed by Oscar Miller from newt oocytes in 1969.…